To view or add a comment, sign in I read the latest The BMJ network meta-analysis comparing pharmacological treatments for overweight and obesity over the weekend
More Melanotan 1 Peptide: Melanocortin Benefits for Skin Pigmentation Research Explore how the melanocortin pathwayparticularly through research peptides like Melanotan 1advances understanding of melanin synthesis, skin pigmentation mechanisms, and photoprotective biology
Tschop recounted his research with DiMarchi and that of others while he accepted the 2023 Banting Medal for Scientific Achievement at the 2023 American Diabetes Association Scientific Sessions.5 The FDA approved the first GLP-1 agonist, twice-a-day Byetta (exenatide), in 2005.1 Since then, several newer and more powerful medications in the GLP-1 agonist class, such as liraglutide and semaglutide, have received FDA approval for type 2 diabetes, with a higher dose of semaglutide FDA approved for weight loss.2 In mid-2022, the first dual agonist, tirzepetide (a combination of a GLP-1 agonist and a GIP), was FDA approved for type 2 diabetes
10.1080/13880209.2022.2148169 88 LittleK.MaJ
